IGSF6 is a novel biomarker to evaluate immune infiltration in mismatch repair-proficient colorectal cancer

Immunotherapy has dramatically changed the landscape of treatment for colorectal cancer (CRC), but currently lack of effective predictive biomarker, especially for tumors with mismatch repair (MMR) proficiency. The response of immunotherapy is associated with the cell–cell interactions in tumor micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rong, Yu-ming, Xu, Yu-cheng, Chen, Xiao-chuan, Zhong, Min-er, Tan, Ying-xin, Liang, Yu-fan, Weng, Jing-rong, Liu, Jun, Wang, Xin-you, Luo, Dan-dong, Bie, Yi-ran, Chen, Xi, Cai, Jia-wei, Yu, Zhao-liang, Zou, Yi-feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663589/
https://www.ncbi.nlm.nih.gov/pubmed/37989761
http://dx.doi.org/10.1038/s41598-023-47739-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663589/
https://www.ncbi.nlm.nih.gov/pubmed/37989761
http://dx.doi.org/10.1038/s41598-023-47739-9

Ejemplares similares